Trademarkia Logo

Australia

AU$
REBLOZYL
Registered: Registered/protected

Last updated on 16 Aug 2021

Owner Info

Celgene Corporation incorporated in the State of Delaware

86 Morris Avenue, Summit

New Jersey, 07901 UNITED STATES OF AMERICA,

Serial Number

2147114 filed on 6 Jan 2021

Correspondent

Spruson & Ferguson

GPO Box 3898,

Sydney, NSW, 2001 AUSTRALIA,

REBLOZYL

Classification Information


Class [005]
Pharmaceutical preparations for use in the treatment of anemia, beta thalassemia, blood disease, cancer.

Mark Details


Serial Number

2147114

Registered On

6 Jan 2021

Renewal On

6 Jan 2031

Mark Type

FIGURATIVE

Legal History


Show more

Status DateAction Taken
16th Aug 2021IP Right Registered correspondence sent
16th Aug 2021IP Right Registration Published
16th Aug 2021Status change to Registered/Protected
7th Jun 2021Application Accepted correspondence sent
7th Jun 2021IP Right has been Examined
7th Jun 2021IP Right Acceptance Published
23rd Mar 2021Early Acceptance Notice correspondence sent
23rd Mar 2021Status change to Accepted
11th Jan 2021Awaiting examination
11th Jan 2021Word and image indexing completed